Ballentine Partners, LLC Johnson & Johnson Transaction History

Ballentine Partners, LLC

  • $5.81 Billion
  • Q3 2024

A detailed history of Ballentine Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Ballentine Partners, LLC holds 56,392 shares of JNJ stock, worth $8.21 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
56,392
Previous 52,119 8.2%
Holding current value
$8.21 Million
Previous $7.62 Million 19.97%
% of portfolio
0.16%
Previous 0.14%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
BUY
$145.48 - $167.38 $621,636 - $715,214
4,273 Added 8.2%
56,392 $9.14 Million
Q2 2024

Aug 06, 2024
SELL
$144.38 - $157.78 $44,469 - $48,596
-308 Reduced 0.59%
52,119 $7.62 Million
Q1 2024

Apr 11, 2024
BUY
$155.22 - $162.74 $1.19 Million - $1.25 Million
7,674 Added 17.15%
52,427 $8.29 Million
Q4 2023

Jan 23, 2024
SELL
$145.6 - $158.88 $450,195 - $491,256
-3,092 Reduced 6.46%
44,753 $7.01 Million
Q3 2023

Oct 19, 2023
SELL
$155.75 - $174.48 $434,854 - $487,148
-2,792 Reduced 5.51%
47,845 $7.45 Million
Q2 2023

Jul 26, 2023
BUY
$154.35 - $166.11 $2.3 Million - $2.48 Million
14,909 Added 41.73%
50,637 $8.38 Million
Q1 2023

Apr 27, 2023
SELL
$151.05 - $180.26 $814,461 - $971,961
-5,392 Reduced 13.11%
35,728 $5.54 Million
Q4 2022

Jan 27, 2023
BUY
$160.2 - $179.79 $756,945 - $849,507
4,725 Added 12.98%
41,120 $0
Q3 2022

Oct 26, 2022
BUY
$161.33 - $179.52 $673,875 - $749,855
4,177 Added 12.96%
36,395 $5.95 Million
Q2 2022

Aug 09, 2022
SELL
$168.19 - $186.01 $75,685 - $83,704
-450 Reduced 1.38%
32,218 $5.72 Million
Q1 2022

May 05, 2022
BUY
$158.14 - $179.59 $839,723 - $953,622
5,310 Added 19.41%
32,668 $5.79 Million
Q4 2021

Feb 14, 2022
BUY
$155.93 - $173.01 $525,172 - $582,697
3,368 Added 14.04%
27,358 $4.68 Million
Q3 2021

Oct 27, 2021
SELL
$161.5 - $179.47 $8,559 - $9,511
-53 Reduced 0.22%
23,990 $3.87 Million
Q2 2021

Aug 12, 2021
BUY
$159.48 - $171.07 $218,328 - $234,194
1,369 Added 6.04%
24,043 $3.96 Million
Q1 2021

May 11, 2021
BUY
$153.07 - $170.48 $77,606 - $86,433
507 Added 2.29%
22,674 $3.73 Million
Q4 2020

Jan 25, 2021
SELL
$137.11 - $157.38 $371,568 - $426,499
-2,710 Reduced 10.89%
22,167 $3.49 Million
Q3 2020

Oct 22, 2020
SELL
$140.38 - $153.83 $87,737 - $96,143
-625 Reduced 2.45%
24,877 $3.7 Million
Q2 2020

Jul 31, 2020
BUY
$128.81 - $155.51 $58,866 - $71,068
457 Added 1.82%
25,502 $3.59 Million
Q1 2020

Apr 23, 2020
BUY
$111.14 - $153.99 $13,781 - $19,094
124 Added 0.5%
25,045 $3.28 Million
Q4 2019

Jan 22, 2020
SELL
$127.5 - $146.44 $12,495 - $14,351
-98 Reduced 0.39%
24,921 $3.64 Million
Q3 2019

Oct 21, 2019
BUY
$126.95 - $142.14 $6,728 - $7,533
53 Added 0.21%
25,019 $3.24 Million
Q2 2019

Jul 25, 2019
BUY
$131.15 - $144.24 $486,304 - $534,841
3,708 Added 17.44%
24,966 $3.48 Million
Q1 2019

May 09, 2019
BUY
$125.72 - $139.79 $7,040 - $7,828
56 Added 0.26%
21,258 $2.97 Million
Q4 2018

Feb 04, 2019
SELL
$122.84 - $147.84 $198,140 - $238,465
-1,613 Reduced 7.07%
21,202 $2.74 Million
Q3 2018

Oct 30, 2018
SELL
$121.58 - $142.88 $10,212 - $12,001
-84 Reduced 0.37%
22,815 $3.15 Million
Q2 2018

Jul 19, 2018
BUY
$119.4 - $131.76 $99,102 - $109,360
830 Added 3.76%
22,899 $2.78 Million
Q1 2018

Apr 26, 2018
SELL
$125.1 - $148.14 $263,961 - $312,575
-2,110 Reduced 8.73%
22,069 $2.83 Million
Q4 2017

Feb 02, 2018
SELL
$131.22 - $143.62 $291,045 - $318,549
-2,218 Reduced 8.4%
24,179 $3.38 Million
Q3 2017

Nov 06, 2017
BUY
$129.47 - $135.38 $3.42 Million - $3.57 Million
26,397
26,397 $3.43 Million

Others Institutions Holding JNJ

# of Institutions
4,275
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email